Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2004
Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trialMasatoshi Akamatsu, Haruhiko Yoshida, Shuntaro Obi, et al.Hepatology International|August 12, 2009
Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesionYukihiro Koike, Haruhiko Yoshida, Shuichiro Shiina, et al.Journal of Gastroenterology|January 17, 2009
Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablationRyosuke Tateishi, Shuichiro Shiina, Takamasa Ohki, et al.Hepato-Gastroenterology|April 9, 2005
Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrenceMasatoshi Akamatsu, Takashi Ishikawa, Yasushi Shiratori, et al.Cancer Chemotherapy and Pharmacology|April 15, 2010
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinomaFumihiko Kanai, Haruhiko Yoshida, Ryosuke Tateishi, et al.Journal of Gastroenterology and Hepatology|February 14, 2007
Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinomaYuji Kondo, Haruhiko Yoshida, Ryosuke Tateishi, et al.Hepato-Gastroenterology|December 13, 2006
Age-related comparison of the profiles of patients with hepatocellular carcinomaTomonori Fujishima, Takashi Ishikawa, Yasushi Shiratori, et al.Proteomics|October 29, 2005
Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatmentTakayuki Kawakami, Yujin Hoshida, Fumihiko Kanai, et al.BMC Gastroenterology|February 28, 2020
Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitisAtsuko Takai, Kentaro Kikuchi, Mayuko Ichimura, et al.Hepatology International|January 24, 2019
The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world settingShuntaro Obi, Takahisa Sato, Shinpei Sato, et al.Pageof 6